Patent details

EP1758587 Title: USE OF A PHARMACEUTICAL COMPOSITION COMPRISING CALCITRIOL AND CLOBETASOL PROPIONATE FOR THE TREATMENT OF PSORIASIS

Basic Information

Publication number:
EP1758587
PCT Application Number:
PCT/FR/2005/001348
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057757627
PCT Publication Number:
WO/2006/008354
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
USE OF A PHARMACEUTICAL COMPOSITION COMPRISING CALCITRIOL AND CLOBETASOL PROPIONATE FOR THE TREATMENT OF PSORIASIS
French Title of Invention:
UTILISATION D'UNE COMPOSITION PHARMACEUTIQUE COMPRENANT DU CALCITRIOL ET DU PROPIONATE DE CLOBETASOL POUR LE TRAITEMENT DU PSORIASIS
German Title of Invention:
VERWENDUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG MIT CALCITRIOL UND CLOBETASOLPROPIONAT ZUR BEHANDLUNG VON SCHUPPENFLECHTE
SPC Number:

Dates

Filing date:
01/06/2005
Grant date:
08/09/2010
EP Publication Date:
08/09/2010
PCT Publication Date:
26/01/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/03/2007
EP B1 Publication Date:
08/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/06/2011
Expiration date:
01/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/06/2005
 
 

Name:
Galderma S.A.
Address:
Zugerstrasse 8, 6330 Cham, Switzerland (CH)

Inventor

Name:
ANDRES Philippe
Address:
France (FR)

Priority

Priority Number:
0406608
Priority Date:
17/06/2004
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/573;
Filing date Document type Number of pages